The trajectory of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the loss of exclusivity in key markets has introduced significant volatility. Investors are now facing the consequences of lower-cost alt